Sign in to view content

Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema

Thomas A. Ciulla, MD, MBA, FASRS

Video
Published 2017

Related

Evaluation of Treatment of High Risk Proliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection (ELYSIAN)
Victor Hugo Gonzalez, MD
On Demand Cases, Courses, and Papers
2018
Impact of Retinal Ischemia on Visual Acuity Outcomes
Michael Peter Fielden, MD, FRCS(C)
Updates from the Field
2016
BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing
Eric W Schneider, MD
Updates from the Field
2019

Category: Diabetic Retinopathy

See more